GlassScriptPhysician profile
Marc A Volpe
NPI 1619940053
$3,600.66
in general payments reported to CMS, 2019-2025
21 companies · $659 in 2025
The $659 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $525 · 2021: $223 · 2022: $707 · 2023: $307 · 2024: $591 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,556.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $989.13 | 2019-2025 | Euflexxa |
| Novo Nordisk INC | $455.25 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Horizon Therapeutics Plc | $380.42 | 2019-2022 | |
| Smith+Nephew, INC. | $349.78 | 2022-2025 | "Acticoat 4"" X 4""", Versajet, Collagenase Santyl |
| Amgen INC. | $338.66 | 2019-2025 | Evenity, Prolia |
| Radius Health, INC. | $224.49 | 2019-2020 | |
| Mvp Orthopedics INC | $160.55 | 2021-2022 | |
| Solventum Corporation | $142.04 | 2024 | Kerramax Care, Activ.A.C., Prevena |
| Bioventus LLC | $117.18 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $86.46 | 2025 | |
| Fidia Pharma USA INC. | $68.25 | 2020-2024 | Triluron, Hymovis, Hyalgan |
| Stryker Corporation | $67.84 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $43.30 | 2022-2023 | Seglentis |
| Endo Pharmaceuticals INC. | $30.79 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $28.75 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $27.74 | 2020-2021 | |
| Pacira Therapeutics, INC. | $24.59 | 2019 | |
| Convatec INC. | $19.67 | 2022 | |
| Theragen, INC. | $17.72 | 2023 | Actastim-S |
| Pacira Pharmaceuticals Incorporated | $15.99 | 2023 | Exparel, Zilretta, Iovera |
| Molnlycke Health Care US, LLC | $12.06 | 2024 | Mepilex Border Post-Op |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Volpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.